206 related articles for article (PubMed ID: 2439789)
21. Butofilolol pharmacokinetics in chronic renal insufficiency.
Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of betaxolol in middle aged patients.
Bianchetti G; Thiercelin JF; Thenot JP
Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans.
Horikiri Y; Suzuki T; Mizobe M
J Pharm Sci; 1998 Mar; 87(3):289-94. PubMed ID: 9523980
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
Regårdh CG
Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
[No Abstract] [Full Text] [Related]
25. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
[TBL] [Abstract][Full Text] [Related]
26. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
Haustein KO; Fritzsche K
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients.
Pfannenstiel P; Rummeny E; Baew-Christow T; Bux B; Cordes M; Adam W; Panitz N; Pabst J; Disselhoff G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S100-5. PubMed ID: 2439779
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacokinetics of ranitidine.
Roberts CJ
Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and disposition of carvedilol in humans.
Neugebauer G; Akpan W; von Möllendorff E; Neubert P; Reiff K
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S85-8. PubMed ID: 2454375
[TBL] [Abstract][Full Text] [Related]
30. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.
Soons PA; Grib C; Breimer DD; Kirch W
Clin Pharmacokinet; 1992 Sep; 23(3):238-48. PubMed ID: 1355019
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of acute phase of myocardial infarction with injectable bisoprolol with oral versus].
Grollier G; Samoyeau R; Potier JC
Therapie; 1991; 46(2):147-54. PubMed ID: 1675817
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetic analysis of bisoprolol.
Grevel J; Thomas P; Whiting B
Clin Pharmacokinet; 1989 Jul; 17(1):53-63. PubMed ID: 2568209
[TBL] [Abstract][Full Text] [Related]
33. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
34. Bisoprolol: a new beta-adrenoceptor blocking drug.
Prichard BN
Eur Heart J; 1987 Dec; 8 Suppl M():121-9. PubMed ID: 2897295
[TBL] [Abstract][Full Text] [Related]
35. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacology and clinical pharmacokinetics of nadolol].
Lazowski J; Wegrzyn B; Lypka A
Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320
[No Abstract] [Full Text] [Related]
39. Cefetamet pivoxil clinical pharmacokinetics.
Blouin RA; Stoeckel K
Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
[TBL] [Abstract][Full Text] [Related]
40. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
